WellDoc partners with American Diabetes Educators Association to add more educational content

By Jonah Comstock
Share

WellDoc announced today a partnership with the American Association of Diabetes Educators (AADE), a professional membership organization of over 14,000 diabetes educators. WellDoc will incorporate educational content from AADE into its FDA-cleared, reimburseable BlueStar system for diabetes management. 

"We were able to build a curriculum that will be able to be delivered in a contextually guided way for our users built off the AADE materials," WellDoc Chief Marketing Officer Tara Charvat told MobiHealthNews. "It’s a beautiful add-on and it’s really a great way for patients to get a more guided curriculum to help them with the self-management of their condition about and beyond the realtime feedback and the other coaching methods that we’ve built on that platform."

WellDoc's BlueStar analyzes patient data, compares the data to past trends, and sends analytics to the patient’s healthcare team. The program is supported by motivational messages, behavioral coaching, and educational content, delivered right to the patient's mobile device. BlueStar is known for being the first reimbursable digital therapeutic.

Through the partnership, BlueStar users will have information delivered to them based on AADE's seven primary areas of self-management: Healthy Eating, Being Active, Monitoring, Taking Medication, Problem Solving, Reducing Risks and Healthy Coping. Educational materials will be re-worked for a digital format, with "bite-sized" lessons being delivered to patients at the moments when they'll have the most impact.

“Digital health is a strong complement to in-person care and education provided by diabetes educators. It is beneficial for AADE to leverage meaningful partnerships with digital health leaders, such as WellDoc, to make every tool available to people living with type 2 diabetes,” AADE CEO Charles MacFarlane said in a statement. “Integrating our curriculum into the BlueStar platform is an important strategic decision for AADE and will benefit our members and people with type 2 diabetes in this evolving healthcare environment. We look forward to continuing to build on this relationship.”